메뉴 건너뛰기




Volumn 298, Issue 3, 2001, Pages 1252-1259

P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; ADENOSINE TRIPHOSPHATASE; CP 141938; GLYCOPROTEIN P; MS 073; MULTIDRUG RESISTANCE PROTEIN; NEUROKININ 1 RECEPTOR ANTAGONIST; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

EID: 0034883081     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (40)

References (28)
  • 5
    • 0033051513 scopus 로고    scopus 로고
    • Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation
    • (1999) Pharm Res , vol.16 , pp. 296-301
    • Chen, C.1    Pollack, G.M.2
  • 19
    • 0028113481 scopus 로고
    • Differential inhibition of foot tapping and chromodacryorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK1 receptor antagonists
    • (1994) Eur J Pharmacol , vol.265 , pp. 179-183
    • Rupniak, N.M.1    Williams, A.R.2
  • 21
    • 0032587925 scopus 로고    scopus 로고
    • The tachykinin NK1 receptor in the brain: Pharmacology and putative functions
    • (1999) Eur J Pharmacol , vol.375 , pp. 51-60
    • Saria, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.